UK Markets closed

AstraZeneca PLC (AZN.L)

LSE - LSE Delayed price. Currency in GBp
Add to watchlist
8,470.00+51.00 (+0.61%)
At close: 4:37PM BST
Full screen
Previous close8,419.00
Open8,464.00
Bid8,451.00 x 0
Ask8,453.00 x 0
Day's range8,430.00 - 8,577.00
52-week range5,871.00 - 9,537.09
Volume1,011,233
Avg. volume2,270,364
Market cap111.15B
Beta (5Y monthly)0.26
PE ratio (TTM)51.74
EPS (TTM)163.70
Earnings date05 Nov 2020
Forward dividend & yield2.16 (2.57%)
Ex-dividend date13 Aug 2020
1y target est78.83
  • The Price Is Right For AstraZeneca PLC (LON:AZN)
    Simply Wall St.

    The Price Is Right For AstraZeneca PLC (LON:AZN)

    AstraZeneca PLC's (LON:AZN) price-to-earnings (or "P/E") ratio of 67.7x might make it look like a strong sell right...

  • Coronavirus update: NY's Cuomo OKs sending students back to school as vaccine optimism rises
    Yahoo Finance

    Coronavirus update: NY's Cuomo OKs sending students back to school as vaccine optimism rises

    New York’s school districts will welcome students back into classrooms in the fall, Governor Andrew Cuomo announced on Friday, as the former coronavirus epicenter continues on its recovery.

  • Japan in deals with AstraZeneca, Novavax for COVID-19 vaccines
    Reuters

    Japan in deals with AstraZeneca, Novavax for COVID-19 vaccines

    Japan plans to buy AstraZeneca Plc's <AZN.L> experimental COVID-19 vaccine and fund a local company to manufacture Novavax's <NVAX.O> vaccine candidate, ramping up its stockpile plan as it battles surging infections. Japan will order 120 million doses of the experimental vaccine developed by the British pharmaceutical company, beginning with 30 million doses by March next year. Separately, Takeda Pharmaceutical <4502.T> said on Friday it would manufacture and sell up to 250 million doses of Novavax's COVID-19 vaccine candidate every year in Japan, with funding support from the government.

By using Yahoo, you agree that we and our partners can use cookies for purposes such as customising content and advertising. See our Privacy Policy to learn more